Theriva Biologics Announces 1-For-25 Reverse Stock Split, Effective August 26, 2024
Portfolio Pulse from Benzinga Newsdesk
Theriva Biologics, Inc. (NYSE:TOVX) announced a 1-for-25 reverse stock split effective August 26, 2024. The split aims to meet NYSE American's per share price requirements. The stock will trade on a split-adjusted basis under the new CUSIP number 87164U 508.
August 16, 2024 | 8:06 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Theriva Biologics is implementing a 1-for-25 reverse stock split to meet NYSE American's per share price requirements. The stock will trade on a split-adjusted basis starting August 26, 2024.
The reverse stock split is a technical adjustment to meet listing requirements and does not change the company's fundamentals. It may stabilize the stock price in the short term but is neutral in terms of long-term value.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100